These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 25603995)

  • 1. Prostate cancer organoids: a potential new tool for testing drug sensitivity.
    Vela I; Chen Y
    Expert Rev Anticancer Ther; 2015 Mar; 15(3):261-3. PubMed ID: 25603995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient derived organoids in prostate cancer: improving therapeutic efficacy in precision medicine.
    Pamarthy S; Sabaawy HE
    Mol Cancer; 2021 Sep; 20(1):125. PubMed ID: 34587953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges, applications and future directions of precision medicine in prostate cancer - the role of organoids and patient-derived xenografts.
    Joshi A; Roberts MJ; Alinezhad S; Williams ED; Vela I
    BJU Int; 2020 Jul; 126(1):65-72. PubMed ID: 32383524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Progress in prostate cancer study: 3D cell culture enables the ex vivo reproduction of tumor characteristics].
    Tostivint V; Racaud-Sultan C; Roumiguié M; Soulié M; Gamé X; Beauval JB
    Presse Med; 2017 Oct; 46(10):954-965. PubMed ID: 28967525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advantages and limitations of 3D organoids and ex vivo tumor tissue culture in personalized medicine for prostate cancer.
    Mickova A; Morong M; Levková M; Kurfúrstová D; Kharaishvili G; Überall I; Student V; Student V; Drapela S; Soucek K; Bouchal J
    Klin Onkol; 2022; 35(6):473-481. PubMed ID: 36513514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3D Hanging Drop Culture to Establish Prostate Cancer Organoids.
    Eder T; Eder IE
    Methods Mol Biol; 2017; 1612():167-175. PubMed ID: 28634942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient derived organoids to model rare prostate cancer phenotypes.
    Puca L; Bareja R; Prandi D; Shaw R; Benelli M; Karthaus WR; Hess J; Sigouros M; Donoghue A; Kossai M; Gao D; Cyrta J; Sailer V; Vosoughi A; Pauli C; Churakova Y; Cheung C; Deonarine LD; McNary TJ; Rosati R; Tagawa ST; Nanus DM; Mosquera JM; Sawyers CL; Chen Y; Inghirami G; Rao RA; Grandori C; Elemento O; Sboner A; Demichelis F; Rubin MA; Beltran H
    Nat Commun; 2018 Jun; 9(1):2404. PubMed ID: 29921838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protocol for generation of and high-throughput drug testing with patient-derived colorectal cancer organoids.
    Tan T; Mouradov D; Gibbs P; Sieber OM
    STAR Protoc; 2024 Jun; 5(2):103090. PubMed ID: 38809757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Throughput Imaging Assay for Drug Screening of 3D Prostate Cancer Organoids.
    Choo N; Ramm S; Luu J; Winter JM; Selth LA; Dwyer AR; Frydenberg M; Grummet J; Sandhu S; Hickey TE; Tilley WD; Taylor RA; Risbridger GP; Lawrence MG; Simpson KJ
    SLAS Discov; 2021 Oct; 26(9):1107-1124. PubMed ID: 34111999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A synopsis of prostate organoid methodologies, applications, and limitations.
    Gleave AM; Ci X; Lin D; Wang Y
    Prostate; 2020 May; 80(6):518-526. PubMed ID: 32084293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3D Cultures of prostate cancer cells cultured in a novel high-throughput culture platform are more resistant to chemotherapeutics compared to cells cultured in monolayer.
    Chambers KF; Mosaad EM; Russell PJ; Clements JA; Doran MR
    PLoS One; 2014; 9(11):e111029. PubMed ID: 25380249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients Lung Derived Tumoroids (PLDTs) to model therapeutic response.
    Delom F; Begiristain I; Grenier T; Begueret H; Soulet F; Siegfried G; Khatib AM; Robert J; Fessart D
    Biochim Biophys Acta Mol Cell Res; 2020 Nov; 1867(11):118808. PubMed ID: 32781095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-throughput cell-based screening of 4910 known drugs and drug-like small molecules identifies disulfiram as an inhibitor of prostate cancer cell growth.
    Iljin K; Ketola K; Vainio P; Halonen P; Kohonen P; Fey V; Grafström RC; Perälä M; Kallioniemi O
    Clin Cancer Res; 2009 Oct; 15(19):6070-8. PubMed ID: 19789329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment and Analysis of Three-Dimensional (3D) Organoids Derived from Patient Prostate Cancer Bone Metastasis Specimens and their Xenografts.
    Lee S; Burner DN; Mendoza TR; Muldong MT; Arreola C; Wu CN; Cacalano NA; Kulidjian AA; Kane CJ; Jamieson CAM
    J Vis Exp; 2020 Feb; (156):. PubMed ID: 32065165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automated microfluidic platform for dynamic and combinatorial drug screening of tumor organoids.
    Schuster B; Junkin M; Kashaf SS; Romero-Calvo I; Kirby K; Matthews J; Weber CR; Rzhetsky A; White KP; Tay S
    Nat Commun; 2020 Oct; 11(1):5271. PubMed ID: 33077832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of conditional reprogramming cell, patient derived xenograft and organoid for drug screening for individualized prostate cancer therapy: Current and future perspectives (Review).
    Cao J; Chan WC; Chow MSS
    Int J Oncol; 2022 May; 60(5):. PubMed ID: 35322860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viability Analysis and High-Content Live-Cell Imaging for Drug Testing in Prostate Cancer Xenograft-Derived Organoids.
    Van Hemelryk A; Erkens-Schulze S; Lim L; de Ridder CMA; Stuurman DC; Jenster GW; van Royen ME; van Weerden WM
    Cells; 2023 May; 12(10):. PubMed ID: 37408211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering prostate cancer in vitro: what does it take?
    Buskin A; Scott E; Nelson R; Gaughan L; Robson CN; Heer R; Hepburn AC
    Oncogene; 2023 Aug; 42(32):2417-2427. PubMed ID: 37438470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient-derived xenografts and organoids model therapy response in prostate cancer.
    Karkampouna S; La Manna F; Benjak A; Kiener M; De Menna M; Zoni E; Grosjean J; Klima I; Garofoli A; Bolis M; Vallerga A; Theurillat JP; De Filippo MR; Genitsch V; Keller D; Booij TH; Stirnimann CU; Eng K; Sboner A; Ng CKY; Piscuoglio S; Gray PC; Spahn M; Rubin MA; Thalmann GN; Kruithof-de Julio M
    Nat Commun; 2021 Feb; 12(1):1117. PubMed ID: 33602919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ex vivo culture of human prostate tissue and drug development.
    Centenera MM; Raj GV; Knudsen KE; Tilley WD; Butler LM
    Nat Rev Urol; 2013 Aug; 10(8):483-7. PubMed ID: 23752995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.